Omnicell

[ACTIVE]

HQ: Cranberry Township, Pennsylvania · Est. 1992 · 1 model registered

Funding gap >24mo

As of Sep 2026, DEPLOY verifies Omnicell: 1 model, $56.0M raised, 1 active incident. 3 sources back the record.

Ownership

ACTIVE

Capital / Funding

$56M

Headquarters

Cranberry Township, Pennsylvania

IP / Patents

Undisclosed

Platform Models

1

Audited Incidents

0

Overview

Omnicell, Inc. (NASDAQ: OMCL) is an American healthcare technology company specializing in medication management automation. Founded in 1992 by Randall Lipps and headquartered in Cranberry Township, Pennsylvania, Omnicell provides the XR2 Automated Central Pharmacy System, automated dispensing cabinets, and IV compounding robots to hospitals and health systems. The company reported $1.185 billion in revenue for fiscal year 2025 and serves thousands of hospitals and pharmacies across North America.

Audited Posture AssessmentPeer Percentile: 75.0%

Safety profile within acceptable range for category. Limited public visibility and press coverage relative to peers.

  • PUBLIC
  • RESEARCH

Key Facts

TickerNASDAQ: OMCL
Revenue1.185 billion USD FY2025
ClientsThousands of hospitals and pharmacies across North America
Product portfolioXR2 Central Pharmacy System, automated dispensing cabinets, i.v.STATION, Medimat

Safety & Regulatory Posture

0 entries
Audited Incident & Recall FootprintLatest event: Apr 2026

1 recall on record (1 serious). Most recent: Apr 2026.

serious: 1

Leadership & Founders

3 entries

Current Program Leadership & Executives

Randall Lippssecondary-verified

Founder, Chairman & CEO

Founding Team

Randall Lipps[Founder]

sole

Randall Lipps[Founder]

no longer at company

Partnerships & Commercial Deployments

0 entries
Total Tracked0
Operating0
Announced0
Concluded0

FAQ

11 entries
What is Omnicell?

Omnicell, Inc. (NASDAQ: OMCL) is an American healthcare technology company specializing in medication management automation. Founded in 1992 by Randall Lipps and headquartered in Cranberry Township, Pennsylvania, Omnicell provides the XR2 Automated Central Pharmacy System, automated dispensing cabinets, and IV compounding robots to hospitals and health systems. The company reported $1.185 billion in revenue for fiscal year 2025 and serves thousands of hospitals and pharmacies across North America.

What does Omnicell make?

Omnicell has 1 robot model on the DEPLOY registry: XR2 Central Pharmacy System (Omnicell builds physical robots).

Who competes with Omnicell?

On the DEPLOY registry, peer companies to Omnicell building in the same form factors include Savoye, Ambi Robotics, DENSO Corporation, FANUC Corporation.

Who is the CEO of Omnicell?

Randall Lipps is the ceo of Omnicell, per the DEPLOY registry.

Where is Omnicell headquartered?

Omnicell is headquartered in Cranberry Township, Pennsylvania, USA.

How much funding has Omnicell raised?

Omnicell has raised approximately $56M in disclosed funding on record in the DEPLOY registry.

Where does Omnicell operate robots?

Omnicell is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Is Omnicell a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Omnicell ranks in roughly the top 25% of companies tracked by the registry.

When was Omnicell founded?

Omnicell was founded in 1992.

Are there any incidents involving Omnicell?

1 active incident involving Omnicell is on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.

Is Omnicell safe?

Omnicell has 1 active incident on record in the DEPLOY registry. 1 recall on record (1 serious). Most recent: Apr 2026. Retracted incidents are excluded from this count.